NCT03563690 is a NA clinical trial of treatment1 in Knee Osteoarthritis, sponsored by Zhejiang Chinese Medical University.

Who is sponsoring NCT03563690?

NCT03563690 is sponsored by Zhejiang Chinese Medical University.

What drugs are being tested in NCT03563690?

Interventions in NCT03563690: treatment1, treatment2, treatment3, treatment4, treatment5, Celebrex.

What condition does NCT03563690 study?

NCT03563690 studies Knee Osteoarthritis.

Is NCT03563690 still recruiting?

NCT03563690 is currently completed. Last updated 8 June 2023.

Last reviewed 2023-06-08 · How we verify

NCT03563690

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Different Kinds of Acupuncture Treatment for Knee Osteoarthritis

Completed NA Last updated 8 June 2023

What this trial tests

NA trial testing treatment1 in Knee Osteoarthritis in 360 participants. Completed in 31 December 2022.

Timeline

3 July 2018

Primary endpoint
28 October 2021

31 December 2022

Quick facts

Lead sponsor	Zhejiang Chinese Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	360
Start date	3 July 2018
Primary completion	28 October 2021
Estimated completion	31 December 2022
Sites	1 location across China

Drugs / interventions tested

treatment1
treatment2
treatment3
treatment4
treatment5
Celebrex (celecoxib) — full drug profile →

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Zhejiang Chinese Medical University

Who can join

Adults 40 to 75, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Knee osteoarthritis (KOA) a chronic disease with symptoms of persistent pain or rest pain , joint stiffness, numbness, limitation of activity and even disability, with significant associated costs and effects on individuals' life quality. Acupuncture as an approach for the management of chronic pain, is receiving increasing recognition from both the public and professionals. The aim of this study is to indicate the effects of three commonly used acupuncture treatments for KOA.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Different kinds of acupuncture treatments for knee osteoarthritis: a multicentre, randomized controlled trial.
Zhang Q, Fang J, Chen L, Wu J, et al · · 2020 · cited 9× · PMID 32171318 · DOI 10.1186/s13063-019-4034-8
Efficacy of Different Acupuncture Techniques for Pain and Dysfunction in Patients with Knee Osteoarthritis: A Randomized Controlled Trial.
Sun J, Liang Y, Luo KT, Shao XM, et al · · 2025 · cited 8× · PMID 39961986 · DOI 10.1007/s40122-025-00713-x
Differential placebo effect of sham acupuncture for chronic pain: a network meta-analysis of randomized controlled trials.
Wan R, Zheng Q, Zeng X, Luo Y, et al · · 2025 · cited 2× · PMID 40890765 · DOI 10.1186/s12906-025-05055-x
Advances in Medical Devices for Augmented Acupuncture Therapy.
Cai R, Yu C, Luo X, Xu N, et al · · 2025 · cited 1× · PMID 40679074 · DOI 10.1002/advs.202505318

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other Zhejiang Chinese Medical University trials

Trials by the same sponsor.

NCT07518433 — Study on Serum Transcriptomics and Metabolomics in Patients With Diabetic Peripheral Neuropathy · not yet recruiting
NCT06330233 — Different Amounts of Moxibustion in the Treatment of DPN: A Clinical RCT Study · NA · active not recruiting
NCT06420778 — The Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With Electroacupuncture · NA · recruiting
NCT05882214 — Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink · Phase 1, PHASE2 · completed
NCT06298318 — Metabolic Changes in Healthy Subjects with Acute Binge Drink · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03563690 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhejiang Chinese Medical University
Last refreshed: 8 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03563690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing